Member Info for Laura2022

About 10 days after the recent Q and A there was the Numab contract so you would hope more to follow given that Peter in his 1st CEO official interview said he has been :

"driving revenues and last few months seen "pipleine momentum

.......significant progress in pipeline "very busy" over last month signals "very positive from new and existing clients" and "watch this space " in terms of updates on contracts"

I have used the info@pyc one but I assume it can't be difficult to ring and ask for Peters ? Would it be worth you emailing Jim ?

As for oublic domain Peter said the pipeline momentum has been strong so I assume we'll get more over the next time frame to add to Numab

Morning KingH

Is it worth emailing Peter,as new CÈO he would want to hear from shareholders ?

Thanks Debull

An interesting article

Through a program called Project Optimus, the FDA is pushing drugmakers to include more patients in early dose-finding trials to get better data on when lower doses can work. A key motivation for the project was "the growing calls from patients and advocates that cancer drugs be more tolerable,” FDA spokesperson Chanapa Tantibanchachai said.

Many of the new cancers drugs were developed using the old strategy. That leads to problems when patients skip doses or stop taking the drugs because of side effects. Some dose recommendations have been officially lowered after the drugs were approved. Other dose-lowering happens one patient at a time. Nearly half of patients in late-stage trials of 28 targeted therapy drugs needed to have their doses lowered, according to one study.

Up to $366,500 to Applied Quantum Materials Inc. (Edmonton, Alta.) and $338,250 to University of Calgary (Calgary, Alta.) for a project with Beyond Blood Diagnostics (U.K.) and the NRC's Nanotechnology Research Centre to develop a circulating tumor cell isolation and detection point of care device

Thankyou Ralph

Was that today please ?

Yet the price doesn't reflect that

Strange

The USA market for bio tech spending seems to have increased massively,hopefully this helps PYC break further into the USA msrket h/clients

This was from another Bio tech discussion group from the poster below

formerlyeasyp

Posts: 786

FT News

12 Feb 2024 19:24

"Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom.

Drug developers raised $6.2bn in equity capital markets in January, according to data from Jefferies. That marked the largest total since February 2021, the same month that the most popular tracker of biotech stocks hit its all-time high.

The funding surge marks a sharp turnaround after a two-year deal drought that forced many companies to cut jobs and shelve projects to save costs, and forced some out of business."

Hi matador

How can they just do this for 10-15 years..keep raising money then send it and end up with billions of shares

Looks like Copl have had enough and qn action group started?

Seems alot of these mining companies are just telling lies for years

VAST COPL RRR

It has to end surely

There must be a reason

Also, just looked at the msuk chart link from last week

The link are in the same position as last August when PYC did 150%

Here's hoping !!

What an amazing rise ,well done

Have a look

At A.I oncology PYC with just £2mln market value ,could do a huge rise like Renx as they are awaiting USA approval for their A.i dosing tool

RENX is a very diffeent stage and business (kidney/renal) but their USA approval on Friday has seen a 400% rise in price,including 400% In their USA securities

Would there be mileage in PYC doing a USA listing further down the road given its Boston based clients?

Certainly looks thet way

I had no idea that it was such such a scientific hub,would that have been the reason for the move? (along with the £35k cost savings )

Sorry 17th and notified today (12th)

Still nearly 4 weeks

Crossed on 12th Jan and notified 17th jan but only notified today by VAL

Coincidence given the tumult?

Great to see bio techs up this much

Amazing and well done

Hopefully same at PYC

£2.14b of equity investment generated at the Park over the last decadeCombined turnover from occupiers at Milton Park reached £10.8b in latest set of financialsFindings coincide with government plan for UK to become science and technology superpower by 2030

New research commissioned by Milton Park reveals that £2.14b of equity investment was generated across 272 companies located at the science, technology and business community over the past decade.

The findings uncovered by high-growth insights firm Beauhurst, show that life science companies at Milton Park secured an impressive 7.56 per cent of the UK’s total equity investment in the sector, equating to £953m. In 2021 alone, £842m of investment was generated – representing a golden age of life sciences, with Immunocore raising £189m, followed by £226m for Exscientia, both of which listed on the NASDAQ stock exchange.

Thanks Trenxh what do you think it signifies?

In other matters buys are 1.43-1.45 so shown as sells or grey

Not sure why ?

Yes

I have noticed that too

Almost every day for the last week ther ehave been 61, 66s